MYR GROUP INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MYR GROUP INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,142	1,403	1,531	2,071	2,247	2,498	3,009	3,644	3,362	3,658
Cost of revenue	1,008	1,278	1,364	1,857	1,972	2,173	2,665	3,280	3,072	3,234
Gross profit	135	125	167	214	276	325	344	364	290	424
Selling, general and administrative	96.4	98.6	119	157	189	207	222	235	238	256
Operating expenses							2,894	3,515	3,308	3,491
Operating income	38.8	29.6	50.3	57.2	86.5	119	115	129	54.1	167
Interest expense	1.3	2.6	3.65	6.23	4.56	1.8	3.56	4.94	6.53	5.65
Interest income	0.01	0	0.02	0	0.01	0.07	0.19	0.89	0.42	0.72
Other non-operating income	0.89	-2.32	-3.62	-0.52	-0.61	-0.53	2.67	-0.04	-1.48	-0.66
Pre-tax income	38.3	24.6	43.1	50.4	81.4	116	114	125	46.5	161
Income tax	16.9	3.49	11.8	14.2	22.6	31.3	30.8	34	16.2	42.9
Net income to minority interests	0	0	0.21	-1.48	0	-0	0	0
Net income	21.4	21.2	31.1	37.7	58.8	85	83.4	91	30.3	118
EBITDA	77.9	68.1	90.2	102	133	165	173	188	119	233
EPS, basic	1.25	1.30	1.89	2.27	3.52	5.05	4.98	5.45	1.84	7.57
EPS, diluted	1.23	1.28	1.87	2.26	3.48	4.95	4.91	5.40	1.83	7.53
Shares, basic (weighted)	17.1	16.3	16.4	16.6	16.7	16.8	16.8	16.7	16.5	15.6
Shares, diluted (weighted)	17.5	16.5	16.6	16.7	16.9	17.2	17	16.8	16.5	15.7

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	23.8	5.34	7.51	12.4	22.7	82.1	51	24.9	3.46	150
Receivables	235	240	288	388	386	375	473	522	653	604
Other current assets	8.2	8.51	8.85	12.8	0.58	0.89	1.85	2.13	1.6	55
Total current assets	343	380	476	639	637	748	890	1,026	929	1,061
Property, plant and equipment	155	148	162	185	185	196	233	269	278	306
Lease right-of-use assets			0	23	22.3	21	30.5	35	42.6	42.4
Goodwill	46.8	47	56.6	66.1	66.1	66.1	116	117	113	115
Intangible assets	11.6	10.9	33.3	54.9	51.4	49.1	87.6	83.5	75.7	72.5
Other non-current assets	2.67	3.66	2.88	3.69	4.26	4.1	3.54	5.6	5.83	9.44
Total assets	573	604	749	1,008	996	1,121	1,399	1,579	1,489	1,644
Accounts payable	99.9	110	139	192	163	201	315	359	295	315
Deferred revenue		30.2	58.5	105	158	168	227	161	237	301
Short-term debt		0	3.68	8.74	4.38	1.04	5.07	7.05	4.36	4.55
Total current liabilities	196	189	284	397	443	499	667	747	664	795
Long-term debt	59.1	79	86.1	157	25	3.46	35.5	29.2	70	54.5
Lease liabilities			0	16.9	15.7	13.2	20.8	25.8	30.5	29.4
Other non-current liabilities	0.54	0.92	1.06	3.3	18.6	11.3	16	25	16.3	10.3
Total liabilities	310	317	424	643	567	602	839	928	888	984
Total debt	59.1	79	89.8	166	29.4	4.5	40.6	36.2	74.4	59
Paid-in capital	140	144	148	153	159	164	161	162	159	165
Retained earnings	123	143	175	212	270	355	405	493	454	503
Other comprehensive income	-0.43	-0.3	-0.19	-0.45	0.02	0.17	-6.3	-3.88	-12.7	-8.18
Shareholders' equity	263	287	323	364	429	519	560	651	600	660
Minority interests		0	1.48	0	0	0
Total equity	263	287	324	364	429	519	560	651	600	660
Total liabilities and equity	573	604	749	1,008	996	1,121	1,399	1,579	1,489	1,644
Shares outstanding	16.3	16.5	16.6	16.6	16.7	16.9	16.6	16.7	16.1	15.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	21.4	21.2	31.3	36.2	58.8	85	83.4	91	30.3	118
Depreciation and amortization	39.1	38.6	39.9	44.5	46.5	46.2	58.2	59.1	65.2	66.5
Stock-based compensation	4.67	4.38	3.17	4.4	5.69	7.5	7.92	8.38	8.53	14.8
Deferred income tax	4.21	-5.09	3.31	3.69	-2.75	6.28	9.57	3.51	-0.4	-10
Change in receivables	-22.5	-35.9	-15.9	-39.7	2.9	10.7	-86.9	-48.5	-134	51.3
Change in payables	17.3	8.15	20	22.5	-43.1	34.3	109	37.3	-61	19.7
Cash from operations	54.5	-9.2	84.8	64.9	175	137	167	71	87.1	327
Capital expenditures	-25.4	-30.8	-50.7	-57.8	-44.4	-52.4	-77.1	-84.7	-75.9	-94.4
Acquisitions	-12.1	0		-79.7	0	0	-111	0	0
Cash from investing	-34.1	-26.5	-93.2	-133	-40.9	-49.3	-186	-79.1	-67.2	-86.2
Stock issued	6.22	1.23	1.9	0.34	0.75	0.5	0.04	0.02	0	0
Share buybacks	-101	-3.06	-1.04	-0.78	0	0	-37	-2.87	-75	-75
Cash from financing	-35.5	16.9	10.6	73.4	-124	-28.1	-9.27	-18.4	-40	-94.1
Exchange rate effect					0.33	-0.41	-3.54	0.34	-1.38	0.38
Net change in cash	-16	-18.5	2.16	4.89	10.3	59.4	-31.1	-26.1	-21.4	147
Free cash flow	29.1	-40	34.1	7.07	131	84.9	90.4	-13.7	11.2	232
Interest paid	1.11	2.26	3.1	5.74	4.07	1.44	2.74	4.15	5.77	5.13
Income taxes paid	6.27	6.6	7.25	13.4	24.2	30	20.5	23.9	15.1	32.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $292.58 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	12.5%	Gross profit / revenue.
Operating margin	5.6%	Operating income / revenue.
EBITDA margin	7.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.5%	Pre-tax income / revenue.
Net margin	4.1%	Net income / revenue.
FCF margin	4.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.5%	Cash from operations / revenue.
Effective tax rate	25.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	9.9%	Net income / average total assets.
SG&A / revenue	6.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.6%	Capital expenditures / revenue.
D&A / revenue	1.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	6.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	46.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	7.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	208.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	13.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	14.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	95.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	10.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	11.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	291.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	12.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	15.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	311.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	15.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	16.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	274.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	24.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	13.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	1,977.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	36.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	12.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	10.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.40x	Current assets / current liabilities.
Quick ratio	1.03x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.18x	(Cash + short-term investments) / current liabilities.
Debt / assets	0.6%	Total debt / total assets.
Liabilities / assets	54.9%	Total liabilities / total assets.
Net debt	-$128.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.44x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	61.0x	Operating income / interest expense.
Working capital	$306.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	10.9%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.40x	Revenue / average total assets.
Fixed asset turnover	12.7x	Revenue / average property, plant and equipment.
Receivables turnover	6.13x	Revenue / average receivables.
Days sales outstanding	60 days	365 x average receivables / revenue.
Days payables	35 days	365 x average accounts payable / cost of revenue.
FCF conversion	117.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	35.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$10.51	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$254.66	Revenue / diluted weighted shares.
FCF per share	$12.29	Free cash flow / diluted weighted shares.
Operating cash flow per share	$18.97	Cash from operations / diluted weighted shares.
Cash per share	$8.86	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.56B	Share price x shares outstanding.
Enterprise value	$4.43B	Market cap + total debt - cash - short-term investments.
P/E	27.6x	Market cap / net income. Only when net income is positive.
P/S	1.14x	Market cap / revenue.
P/FCF	23.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	15.3x	Market cap / cash from operations, when positive.
EV/Sales	1.11x	Enterprise value / revenue.
EV/EBIT	19.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	15.0x	Enterprise value / EBITDA, when both are positive.
EV/FCF	22.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.2%	Free cash flow / market cap.
Earnings yield	3.6%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.
PEG	1.80x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was MYR GROUP INC.'s revenue in fiscal 2025?

MYR GROUP INC. reported revenue of $3.66B for fiscal 2025, 8.8% higher than the year before.

Was MYR GROUP INC. profitable in fiscal 2025?

Yes. Net income was $118.4M, a net margin of 3.2%.

How much free cash flow did MYR GROUP INC. generate in fiscal 2025?

Cash from operations of $326.6M minus capital expenditures of $94.4M left free cash flow of $232.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MYR GROUP INC.